中文 | English
Liver cirrhosis is a late-stage condition in which healthy liver tissue is permanently replaced by scar tissue (fibrosis), severely impairing liver function. It represents the end result of chronic liver damage from various causes including hepatitis B and C, chronic alcohol use, non-alcoholic steatohepatitis (NASH), and autoimmune conditions.
Cirrhosis develops gradually over years or even decades, often without noticeable symptoms in its early stages (compensated cirrhosis). As the disease progresses to decompensated cirrhosis, serious complications arise including portal hypertension, ascites (fluid accumulation), variceal bleeding, hepatic encephalopathy, and hepatocellular carcinoma.
At Dr. Jing Tong Gastroenterology in Flushing, we provide comprehensive cirrhosis management using the latest evidence-based approaches. Early detection through non-invasive fibrosis assessment, combined with diligent monitoring and treatment, can significantly slow disease progression and prevent life-threatening complications.
Advanced fellowship training at one of America's premier medical institutions with specialized hepatology expertise.
Licensed in therapeutic endoscopy for variceal band ligation and other advanced procedures critical for cirrhosis management.
Fluent in English, Mandarin, and Cantonese to ensure patients and families fully understand complex treatment plans.
Structured surveillance programs including regular cancer screening and complication prevention strategies.
Early-stage fibrosis can sometimes be reversed by treating the underlying cause. However, advanced cirrhosis with extensive scarring is generally irreversible. The key is early detection and aggressive treatment to prevent progression.
We use FibroScan (transient elastography), a painless, non-invasive test that measures liver stiffness to assess fibrosis stage. Combined with blood tests like FIB-4 and APRI scores, we can accurately stage liver disease without a biopsy in most cases.
Portal hypertension is increased blood pressure in the portal vein system caused by scarred liver tissue blocking blood flow. It can lead to enlarged veins (varices) in the esophagus and stomach that can rupture and bleed, which is a medical emergency.
All patients with cirrhosis should undergo liver cancer screening every 6 months with abdominal ultrasound and AFP blood testing. This regular surveillance is essential for detecting hepatocellular carcinoma at a treatable stage.
Liver transplant is considered when cirrhosis reaches decompensated stage with complications that cannot be controlled with medications, or when liver cancer meets transplant criteria. Dr. Tong works closely with transplant centers for timely referrals.
Don't wait for complications. Schedule your evaluation with Dr. Jing Tong today.
